KORU Medical Systems (NASDAQ:KRMD – Get Free Report) and Phreesia (NYSE:PHR – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for KORU Medical Systems and Phreesia, as provided by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| KORU Medical Systems | 1 | 1 | 4 | 0 | 2.50 |
| Phreesia | 1 | 1 | 17 | 0 | 2.84 |
KORU Medical Systems presently has a consensus price target of $6.50, suggesting a potential upside of 47.39%. Phreesia has a consensus price target of $28.94, suggesting a potential upside of 157.42%. Given Phreesia’s stronger consensus rating and higher possible upside, analysts plainly believe Phreesia is more favorable than KORU Medical Systems.
Volatility and Risk
Insider & Institutional Ownership
58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 92.1% of Phreesia shares are held by institutional investors. 20.6% of KORU Medical Systems shares are held by insiders. Comparatively, 5.5% of Phreesia shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
Profitability
This table compares KORU Medical Systems and Phreesia’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| KORU Medical Systems | -6.41% | -15.90% | -9.77% |
| Phreesia | -1.16% | -1.31% | -0.94% |
Earnings and Valuation
This table compares KORU Medical Systems and Phreesia”s top-line revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| KORU Medical Systems | $41.13 million | 4.97 | -$2.64 million | ($0.06) | -73.50 |
| Phreesia | $419.81 million | 1.61 | -$58.53 million | ($0.10) | -112.43 |
KORU Medical Systems has higher earnings, but lower revenue than Phreesia. Phreesia is trading at a lower price-to-earnings ratio than KORU Medical Systems, indicating that it is currently the more affordable of the two stocks.
Summary
Phreesia beats KORU Medical Systems on 9 of the 14 factors compared between the two stocks.
About KORU Medical Systems
KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.
About Phreesia
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, a self-service intake tablets; and Arrivals Kiosks, an on-site kiosks. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is based in Wilmington, Delaware.
Receive News & Ratings for KORU Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for KORU Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.
